Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) is an enzyme that catalyzes the cis-trans isomerization of specific pSer/Thr-Pro motifs within target proteins, modulating their conformation, function, and stability. It plays a role in cell cycle regulation, signal transduction, and metabolism. PIN1 is implicated in diseases such as cancer and Alzheimer's disease, making it a potential therapeutic target.
Inhibition of PIN1 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1).